Literature DB >> 12037043

Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe.

James R Johnson1, Adam L Stell, Timothy T O'Bryan, Michael Kuskowski, Bogdan Nowicki, Candice Johnson, Joel N Maslow, Anil Kaul, Justine Kavle, Guillem Prats.   

Abstract

Escherichia coli O15:K52:H1 is a significant extraintestinal pathogen in Europe (G. Prats et al., J. Clin. Microbiol. 38:201-209, 2000). To search for evidence of this clonal group outside of Europe, 75 non-European E. coli isolates of serogroup O15 were compared with five members of the O15:K52:H1 clonal group from Barcelona, Spain, according to genomic background, virulence genotypes, and antimicrobial resistance profiles. Amplification phylotyping showed that 16 (21%) of the 75 non-European O15 isolates corresponded with the O15:K52:H1 clonal group. The 16 non-European O15:K52:H1 clonal group members represented diverse geographic locales. They were isolated almost exclusively from humans with extraintestinal infections and accounted for 50% of all O15 isolates from five human clinical collections studied. Most non-European clonal group members exhibited a consensus virulence factor profile that included the F16 or F7-2 papA alleles (P fimbrial structural subunit), papG allele II (P fimbrial adhesin), iha (putative adhesin siderophore), and iutA (aerobactin receptor). This resembles the virulence profiles of (i) European representatives of the O15:K52:H1 clonal group and (ii) phylogenetically related "clonal group A," a recently recognized significant contributor to trimethoprim-sulfamethoxazole resistance in the United States (A. R. Manges et al., N. Engl. J. Med. 345:1007-1013, 2001). Antimicrobial resistance profiles were variable, and resistance was inconsistently transferred by conjugation. These findings indicate that the O15:K52:H1 clonal group is broadly distributed beyond Europe, exhibits previously unrecognized phenotypic and genotypic diversity, and contributes significantly to extraintestinal infections in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12037043      PMCID: PMC130829          DOI: 10.1128/JCM.40.6.1913-1923.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Improved repetitive-element PCR fingerprinting of Salmonella enterica with the use of extremely elevated annealing temperatures.

Authors:  J R Johnson; C Clabots
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  A comparative study of nosocomial and community-acquired strains of Escherichia coli causing bacteraemia in a Danish University Hospital.

Authors:  B Olesen; H J Kolmos; F Orskov; I Orskov
Journal:  J Hosp Infect       Date:  1995-12       Impact factor: 3.926

3.  Escherichia coli serotype O15:K52:H1 as a uropathogenic clone.

Authors:  G Prats; F Navarro; B Mirelis; D Dalmau; N Margall; P Coll; A Stell; J R Johnson
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay.

Authors:  J R Johnson; A L Stell; F Scheutz; T T O'Bryan; T A Russo; U B Carlino; C Fasching; J Kavle; L Van Dijk; W Gaastra
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  Chromosomal regions specific to pathogenic isolates of Escherichia coli have a phylogenetically clustered distribution.

Authors:  E F Boyd; D L Hartl
Journal:  J Bacteriol       Date:  1998-03       Impact factor: 3.490

6.  Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains.

Authors:  E Bingen; B Picard; N Brahimi; S Mathy; P Desjardins; J Elion; E Denamur
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

7.  Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise.

Authors:  J R Johnson; A L Stell
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

8.  Molecular characterization of the gene encoding H antigen in Escherichia coli and development of a PCR-restriction fragment length polymorphism test for identification of E. coli O157:H7 and O157:NM.

Authors:  P I Fields; K Blom; H J Hughes; L O Helsel; P Feng; B Swaminathan
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

9.  Clonal relationships among bloodstream isolates of Escherichia coli.

Authors:  J N Maslow; T S Whittam; C F Gilks; R A Wilson; M E Mulligan; K S Adams; R D Arbeit
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

10.  Sex in Escherichia coli does not disrupt the clonal structure of the population: evidence from random amplified polymorphic DNA and restriction-fragment-length polymorphism.

Authors:  P Desjardins; B Picard; B Kaltenböck; J Elion; E Denamur
Journal:  J Mol Evol       Date:  1995-10       Impact factor: 2.395

View more
  21 in total

1.  Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains.

Authors:  Concetta Restieri; Geneviève Garriss; Marie-Claude Locas; Charles M Dozois
Journal:  Appl Environ Microbiol       Date:  2007-01-12       Impact factor: 4.792

2.  Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis.

Authors:  James R Johnson; Michael A Kuskowski; Timothy T O'bryan; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Three-decade epidemiological analysis of Escherichia coli O15:K52:H1.

Authors:  Bente Olesen; Flemming Scheutz; Megan Menard; Marianne N Skov; Hans Jørn Kolmos; Michael A Kuskowski; James R Johnson
Journal:  J Clin Microbiol       Date:  2009-04-01       Impact factor: 5.948

4.  Enteroaggregative Escherichia coli O78:H10, the cause of an outbreak of urinary tract infection.

Authors:  Bente Olesen; Flemming Scheutz; Rebecca L Andersen; Megan Menard; Nadia Boisen; Brian Johnston; Dennis S Hansen; Karen A Krogfelt; James P Nataro; James R Johnson
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

5.  Molecular analysis of antimicrobial-susceptible and -resistant Escherichia coli from retail meats and human stool and clinical specimens in a rural community setting.

Authors:  Elizabeth Lyon Hannah; James R Johnson; Frederick Angulo; Bassam Haddadin; Jacquelyn Williamson; Matthew H Samore
Journal:  Foodborne Pathog Dis       Date:  2009-04       Impact factor: 3.171

6.  Role of enteroaggregative Escherichia coli virulence factors in uropathogenesis.

Authors:  Erik J Boll; Carsten Struve; Nadia Boisen; Bente Olesen; Steen G Stahlhut; Karen A Krogfelt
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

7.  European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis.

Authors:  Simone Cagnacci; Laura Gualco; Eugenio Debbia; Gian Carlo Schito; Anna Marchese
Journal:  J Clin Microbiol       Date:  2008-06-25       Impact factor: 5.948

8.  Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004.

Authors:  James R Johnson; Megan Menard; Brian Johnston; Michael A Kuskowski; Kim Nichol; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

9.  The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections.

Authors:  A R Manges; P Natarajan; O D Solberg; P S Dietrich; L W Riley
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

10.  Rapid and specific detection of Escherichia coli clonal group A by gene-specific PCR.

Authors:  James R Johnson; Krista Owens; Amee R Manges; Lee W Riley
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.